Bank Of Montreal Aldeyra Therapeutics, Inc. Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$2.43 - $4.85 $196,101 - $391,395	80,700 New	80,700 $324,000
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $256,120 - $364,826	-32,257 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.44 - $14.85 $336,763 - $479,016	32,257 New	32,257 $383,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $283M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.